Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
US stocks are modestly higher as investors await details of President-elect Biden’s multi-trillion-dollar stimulus package, further clues if some Fed members are becoming a little bit...
What normally takes decades has been achieved in 12 months, without cutting corners.
Credit: Image: Karim Rafie “The findings provide an increased understanding of how the virus gets through the stomach and intestinal system. Continued research can provide answers...
Scientists and government sources claimed today that Johnson & Johnson’s single-jab COVID-19 vaccine could be given emergency use authorization as early as next month, according to...
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine
It may be two months before Moderna and the NIH can conclude whether they can halve their vaccine dose and provide the same level of protection
More than 3.1 billion doses have been ordered worldwide of the Oxford-AstraZeneca vaccine, providing a ray of hope in the fight against the pandemic.
UK First To Approve Astra-Zeneca Vaccine As "Tier 4" Lockdowns Expanded Even as regulators in the EU opt to give the approval process for the adenovirus-vector...
The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the The post AZ COVID-19 vaccine cleared in UK,...
The UK’s COVID-19 immunization program could get a speed boost, with the country’s drugs regulator expected to make a ruling on AstraZeneca
Once one of the hottest brands in biotech, Patrick Soon-Shiong’s next-gen cancer brainchild NantKwest has taken its lumps in recent years with little to show from...
CNBC Transcript: Dr. Anthony Fauci speaks with CNBC ’s Meg Tirrell live during the CNBC Healthy Returns Livestream today and gives his predictions for coronavirus after...
AstraZeneca, which is jointly developing a Covid-19 vaccine with the University of Oxford, plans to begin clinical trials testing the company's vaccine in combination with Russia’s...
British drugmaker AstraZeneca is already running behind early competitors in the hunt for a Covid-19 vaccine with interim data that have received less-than-stellar feedback. With those...
Paul Peter Tak has done it all: From a professorship in his native Netherlands to the head of immunoInflammation R&D at GlaxoSmithKline, from leading small biotechs...
Though the White House is planning on hosting a “Vaccine Summit” on Tuesday, two major players will not be attending. Pfizer and Moderna have both reportedly...
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial...
After AZN Hack Accusation, Kim Jong Un Given COVID Vaccine By China Tyler Durden Mon, 11/30/2020 - 22:30 Authored by Harry Kazianis via 19fortyfive.com North Korean...
There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may...
It took Oxford University’s brightest minds decades of work to give them the expertise to develop a Covid-19 vaccine.
Demand for vaccine storage freezers, three companies told GEN, extends beyond traditional customers such as biopharmas and academic labs to include healthcare providers and pharmacies, many...
AstraZeneca COVID-19 Vaccine 70% Effective, UK Expects Millions Of Doses By Year's End Tyler Durden Mon, 11/23/2020 - 06:21 Continuing the pattern of leading COVID-19 vaccine...
Coronavirus vaccine results are pouring in, and it's good news for older people
AstraZeneca COVID-19 Vaccine Shows Immune Response In Elderly
UK eyes access deal as Moderna’s COVID-19 shot hits the mark
COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets
Hungary steps out of line with EU to order Russia’s COVID-19 vaccine
"A Vaccine For The Rich" - Pfizer's COVID-19 Jab Almost Impossible To Distribute In Poorer Countries
Coronavirus vaccine: what we know so far – a comprehensive guide by academic experts